Clinical Trial Update: Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 [Phase 2]

View source ↗

Summary

A Phase 2 long-term extension study comparing maintenance treatment for anemia in chronic kidney disease patients on hemodialysis receiving epoetin alfa/beta ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• BAY85-3934
• EPOETIN ALFA (EPOETIN ALFA)
• epoetin beta (epoetin beta)

Snippet

Sponsor: Bayer | Conditions: Anemia, Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED